RxDoctor Payments Data

David Stobie

Physician Assistant · Seneca Falls, NYNPI 1528225034

Payments from drug & device makers

$3,954in general payments, 2019–2025

Across 216 payments — averaging $18.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$767
  • Pfizer$632
  • Novo Nordisk$468
  • AbbVie$235
  • GSK$223
  • Lilly USA, LLC$217
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$3,954100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,954 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter181$123,716
Humira(Cf) PenAdalimumab14$102,236
OzempicSemaglutide82$90,302
EliquisApixaban70$82,140
JardianceEmpagliflozin57$67,645
TrulicityDulaglutide35$32,217
JanuviaSitagliptin Phosphate22$31,022
InvokanaCanagliflozin19$28,765
Spiriva RespimatTiotropium Bromide43$24,498
Breo ElliptaFluticasone/Vilanterol50$22,860
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr36$20,885
FarxigaDapagliflozin Propanediol19$19,886
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$14,016
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$12,860
MounjaroTirzepatide12$12,057

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$223$173,718287 claims
Boehringer IngelheimJardiance, Spiriva Respimat$61$92,143100 claims
Novo NordiskOzempic$468$90,30282 claims
PfizerEliquis$632$82,14070 claims
Lilly USA, LLCTrulicity, Mounjaro$217$44,27447 claims
MerckJanuvia, Janumet Xr$69$41,93037 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$767$39,70064 claims
Johnson & JohnsonInvokana$11$28,76519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Seneca Falls

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →